抗癌佐xaborols 通过直接抑制 CPSF3 来阻止 mRNA 前处理
Ye Tao1, Albert Budhipramono2, Ji Huang3
1Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Cell chemical biology
|November 15, 2023
概括
新型佐xaborols通过抑制CPSF3,一种对基因表达至关重要的酶来杀死癌细胞. 这一发现为开发向癌症疗法开辟了新的途径,通过向这种特定机制来开发向癌症疗法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 一个新型的佐xaboroles类已经证明了诱导癌症细胞死亡的能力.
- 佐xaborol诱导的癌细胞死亡背后的精确机制仍未确定.
研究的目的:
- 阐明佐xaboroles诱导癌细胞死亡的机制.
- 确定佐xaboroles的分子标及其在癌症生物学中的作用.
主要方法:
- 利用先进的遗传学平台来识别耐药机制.
- 采用体外生化测试来评估酶抑制.
- 进行了X射线结晶学,以确定佐xaborols与CPSF3.3的结合方式.
- 评估了佐xaboroles 在各种癌症细胞系上的抗癌作用.
主要成果:
- 发现分离和多基化特异因子3 (CPSF3) 的突变会给佐xaboroles带来耐药性.
- 在实验室中,佐xaboroles被证明可以抑制CPSF3的内核酶活性.
- 佐xaboroles 抑制 CPSF3 抑制了细胞中的转录终结,导致基本基因的下调.
- X射线结晶学揭示了佐xaborles和CPSF3.3的活性位点之间独特的结合相互作用.
- 佐xaborole化合物有效地阻碍了各种癌症细胞系的生长.
结论:
- 本佐xaboroles通过抑制CPSF3的内核酶活性来起作用,CPSF3是前mRNA处理和转录终止中的关键酶.
- 佐xaborols与CPSF3的独特结合机制为药物开发提供了一种新的方法.
- 本佐xaboroles显示显著的潜力作为一种新的类型的CPSF3抑制剂用于癌症治疗.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:31The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K